PHARMALA BIOTECH HOLDINGS INC. financial statements, including revenue, expenses, profit, and loss
The total revenue of MDMA for the last quarter is 90.42 k CAD, and it's 87.98% lower compared to the previous quarter. The net income of Q2 24 is -222.57 k CAD.